Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Wilms Tumor 9Leukemia, Myeloid, Acute 9Glioma 9Osteosarcoma 8Neuroblastoma 8Multiple Myeloma 8Sarcoma 7Rhabdoid Tumor 7Prostatic Neoplasms 7Neoplasm Metastasis 7Lymphoma, Non-Hodgkin 7Hepatoblastoma 7Rhabdomyosarcoma 6Neuroectodermal Tumors, Primitive, Peripheral 6Medulloblastoma 6Lymphoma 6Lung Neoplasms 6Histiocytosis, Langerhans-Cell 6Ependymoma 6Colorectal Neoplasms 6Breast Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 5Central Nervous System Neoplasms 5Carcinoma, Hepatocellular 5Sarcoma, Ewing 4Ovarian Neoplasms 4Melanoma 4Carcinoma, Non-Small-Cell Lung 4Burkitt Lymphoma 4

Interventions

Cyclophosphamide 18fludarabine phosphate 12pembrolizumab 11Brentuximab Vedotin 11fludarabine 10Nivolumab 10Mycophenolic Acid 10Whole-Body Irradiation 9Doxorubicin 9Dacarbazine 9Vinblastine 7Magnetic Resonance Spectroscopy 7Filgrastim 7Etoposide 7Cyclosporine 7Specimen Handling 6Peripheral Blood Stem Cell Transplantation 6Sirolimus 5Radiotherapy 5Melphalan 5Granulocyte Colony-Stimulating Factor 5Busulfan 5Tacrolimus 4Gemcitabine 4pegfilgrastim 3Vinorelbine 3Radiation 3Cyclosporins 3Carmustine 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × X-Rays × 90 days × Clear all
NCT03418038 2026-04-16

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Mayo Clinic

Phase 2 Recruiting
80 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡